FUJIFILM Canada plans to expand its offerings
April 24, 2019
MISSISSAUGA, Ont. – FUJIFILM Canada Inc. has announced the establishment of the new Medical Systems Division. The new division is expected to greatly expand the commercialization of Fujifilm state-of-the-art diagnostic imaging systems and make available the latest technologies to hospitals, clinics and healthcare providers in Canada.
In the future, FUJIFILM Canada Inc. plans to introduce a large portfolio of diagnostic imaging systems to the Canadian market.
For the past 50 years, Fujifilm has worked together with Christie Innomed, who will continue to be the sole and exclusive authorized Canadian distributor of Fujifilm’s Synapse complete Healthcare IT portfolio, as well as an authorized Canadian distributor of select premium Computed and Digital Radiography (CR/DR) imaging solutions. Fujifilm will continue to work in close collaboration with Christie Innomed.
In the near future, FUJIFILM Canada Inc., Medical Systems Division plans to introduce a broad range of DR and women’s health solutions, including a variety of portable X-ray systems, a complete DR suite, a new generation of flat panel detectors and a full field digital mammography solution with digital breast tomosynthesis.
“Fujifilm is a company of ‘firsts’ in diagnostic imaging. In 1936, we began manufacturing X-ray films; and in 1983, we pioneered the first digitized radiography system in the world,” said Michio Kondo (pictured), president of FUJIFILM Canada, Inc. “We are honored to expand our presence in Canada with the launch of our Medical Systems Division.”
Christie Innomed continues to be the sole and exclusive authorized distributor of the Fujifilm’s Synapse® healthcare IT portfolio while also providing select premium Fujifilm diagnostic imaging solutions and services to hospitals, clinics and healthcare providers in Canada.
Fujifilm’s healthcare IT solutions drive operational efficiency across the continuum of care to offer true interoperability and secure accessibility to patient images and records. Ground-breaking Fujifilm Synapse technologies combined with Christie Innomed’s integration and support expertise meet the complex needs of Canadian healthcare institutions.
“The focus on our mission is as sharp as it has ever been and we remain dedicated to providing best in class, leading healthcare technologies from renowned manufacturers to enhance workflow and patient outcomes,” said Martin Roy, president and CEO, Christie Innomed. “Our 50-year partnership with Fujifilm is a great testimonial of our true long-term commitment to delivering quality systems and healthcare IT solutions for our customers.”
With this new step, FUJIFILM Canada, Inc. and Christie Innomed each have a common mission to deliver unparalleled value to the Canadian market, through offering advanced technologies and highly customizable, enduring solutions.
FUJIFILM Canada Inc. sells and markets a range of Fujifilm products and services across a broad range of industries including consumer and commercial photo imaging, and industrial products. The Imaging Division includes instax® instant cameras and film, film and one-time-use cameras, photographic paper, digital printing equipment, personalized photo products, motion picture archival film, digital cameras, and products and services to the graphic printing industry. The Medical Systems Division will offer solutions in diagnostic imaging technologies. Fujifilm industrial offerings include products for non-destructive testing and pressure measurement film. For more information, please visit www.Fujifilm.ca
About FUJIFILM Holdings Corporation
FUJIFILM Holdings Corporation, Tokyo, Japan brings cutting-edge solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies developed in its relentless pursuit of innovation. Its proprietary core technologies contribute to the various fields including healthcare, graphic systems, highly functional materials, optical devices, digital imaging and document products. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic and imaging technologies. For the year ended March 31, 2018, the company had global revenues of $23.0 billion, at an exchange rate of 106 yen to the dollar. Fujifilm is committed to environmental stewardship and good corporate citizenship. For more information, please visit www.fujifilmholdings.com.
About Christie Innomed
Established in 1954, Christie Innomed develops, distributes, integrates and supports innovative medical imaging and health information management solutions improving Canadian healthcare. Christie Innomed is a leading medical imaging distributor with over 200 dedicated specialists servicing over 1500 hospitals and clinics with their 5 offices throughout Canada. We are focused on bringing innovative technologies to Canadian healthcare institutions in the areas of medical imaging, medical informatics and healthcare IT solutions. For more information, please visit www.christieinnomed.com.